Chaoju Eye Care Holdings Limited
HKSE: 2219.HK0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Hong Kong Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- CEO
- Bozhou Zhang
- Employees
- 2,608
- Headquarters
- Beijing, China
- IPO year
- 2021
- Market cap
- HK$2.0B
- Website
- https://www.chaojueye.com
Loading 2219…
Loading profile data…Frequently asked questions about 2219
What does Chaoju Eye Care Holdings Limited (2219.HK) do?
Chaoju Eye Care Holdings Limited owns and operates a network of ophthalmic hospitals and optical centers in China. Its consumer ophthalmic services include treatments and prevention for various ophthalmic disorders, such as refractive and presbyopia correction, and myopia control, as well as optical products and services. The company also provid...
Where does 2219.HK trade?
Chaoju Eye Care Holdings Limited (2219.HK) trades on the Hong Kong Stock Exchange.
What sector is 2219.HK in?
Chaoju Eye Care Holdings Limited (2219.HK) operates in the Healthcare sector, specifically in the Medical - Care Facilities industry.
Who is the CEO of Chaoju Eye Care Holdings Limited?
Bozhou Zhang is the chief executive officer of Chaoju Eye Care Holdings Limited (2219.HK).
Where is Chaoju Eye Care Holdings Limited headquartered?
Chaoju Eye Care Holdings Limited is headquartered in China.
Does 2219.HK pay a dividend?
Yes — Chaoju Eye Care Holdings Limited (2219.HK) paid a trailing twelve-month dividend of HKD 0.12 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 2219.HK go public?
Chaoju Eye Care Holdings Limited (2219.HK) completed its initial public offering in 2021.